708
ODN 2216-Type A (Human, Negative Control) | VAdv-Ly0075
(No reviews yet)
Write a Review
- SKU:
- 708-VAdv-Ly0075-GEN
Description
ODN 2216-Type A (Human, Negative Control) | VAdv-Ly0075 | Gentaur UK, US & Europe Distribution
Short Description: ODN 2216-Type A, Human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.
Status: customized
Expected Delivery Time: inquire
Related Products
ODN 2336-Type A (Human, Negative Control) | VAdv-Ly0077
708
€4,995.00 - €15,120.00
ODN 2336-Type A (Human, Negative Control) | VAdv-Ly0077 | Gentaur UK, US & Europe Distribution Short Description: ODN 2336-Type A, Human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant...
708-VAdv-Ly0077-GEN
ODN 2216-Type A (Human) | VAdv-Ly0066
708
€5,526.00 - €17,250.00
ODN 2216-Type A (Human) | VAdv-Ly0066 | Gentaur UK, US & Europe Distribution Short Description: ODN 2216-Type A, Human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. Status: ...
708-VAdv-Ly0066-GEN
ODN 2216-Type A (Human, FITC Conjugate) | VAdv-Ly0048
708
€2,328.00
ODN 2216-Type A (Human, FITC Conjugate) | VAdv-Ly0048 | Gentaur UK, US & Europe Distribution Short Description: ODN 2216-Type A, Human TLR9 agonist, FITC conjugate, oligodeoxy nucleotide...
708-VAdv-Ly0048-GEN
ODN 2216-Type A (Human, Biotin Conjugate) | VAdv-Ly0047
708
€2,328.00
ODN 2216-Type A (Human, Biotin Conjugate) | VAdv-Ly0047 | Gentaur UK, US & Europe Distribution Short Description: ODN 2216-Type A, Human TLR9 agonist, biotin conjugate, oligodeoxy nucleotide...
708-VAdv-Ly0047-GEN
ODN 2006-Type B (Human, Negative Control) | VAdv-Ly0070
708
€15,120.00
ODN 2006-Type B (Human, Negative Control) | VAdv-Ly0070 | Gentaur UK, US & Europe Distribution Short Description: ODN 2006-Type B, Human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant...
708-VAdv-Ly0070-GEN